Fund Holdings — Lynx1 Capital Management LP

Total Portfolio Value:
$276.70M
Total Bought:
$52.78M
Total Sold:
$154.06M
Net Transaction:
-$101.27M
Notable People:
Weston Agnew Nichols
Securities
▲▼
SharesValue
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Merus N V1,509,0071,206,707-302,300$67.95M$71.40M25.80%+$3.45M
Stoke Therapeutics, Inc.(STOK)3,696,8205,185,191+1,488,371$49.91M$70.05M25.32%+$20.14M
GH Research PLC(GHRS)3,310,5633,966,726+656,163$35.29M$46.25M16.72%+$10.96M
C4 Therapeutics, Inc.(CCCC)3,634,6626,880,527+3,245,865$29.70M$31.79M11.49%+$2.09M
TScan Therapeutics, Inc.(TCRX)5,224,6005,224,6000$41.48M$30.56M11.05%-$10.92M
Cullinan Therapeutics, Inc.(CGEM)0377,323+377,323$0$6.58M2.38%+$6.58M
Allogene Therapeutics Inc02,228,295+2,228,295$0$5.19M1.88%+$5.19M
Longboard Pharmaceuticals In0167,317+167,317$0$4.52M1.63%+$4.52M
Passage Bio, Inc.(PASG)4,845,8715,057,629+211,758$6.54M$4.02M1.45%-$2.53M
Cabaletta Bio, Inc.(CABA)2,082,973492,103-1,590,870$35.54M$3.68M1.33%-$31.85M
iBio, Inc.CON NEW(IBIO)600,000600,0000$2.44M$1.27M0.46%-$1.17M
Bionomics LimitedADS814,467599,673-214,794$838.9K$459.9K0.17%-$379.0K
Pieris Pharmaceuticals Inc043,499+43,499$0$426.8K0.15%+$426.8K
Kiniksa Pharmaceuticals International, plcCL A(KNSA)09,500+9,500$0$177.4K0.06%+$177.4K
Centessa Pharmaceuticals PlcADS17,40017,4000$196.6K$157.1K0.06%-$39.5K
Korro Bio, Inc.(KRRO)03,800+3,800$0$128.7K0.05%+$128.7K
Yarrow Bioscience Inc(YARW)016,194+16,194$0$31.9K0.01%+$31.9K
Alpine Immune Sciences Inc2,253,1830-2,253,183$89.32M$0—-$89.32M
Autolus Therapeutics plcADS(AUTL)1,390,1600-1,390,160$8.87M$0—-$8.87M
Kinnate Biopharma Inc1,981,1060-1,981,106$5.27M$0—-$5.27M
Nektar Therapeutics(NKTR)2,068,8420-2,068,842$1.93M$0—-$1.93M
Pieris Pharmaceuticals Inc8,779,1620-8,779,162$1.61M$0—-$1.61M
Silence Therapeutics plcADS(SLN)526,6420-526,642$11.38M$0—-$11.38M
Page 1 of 1
Lynx1 Capital Management LP — 13F Holdings — Q2 2024 | TickerTrail